Next Article in Journal
Penicillin G Sodium as a Treatment of Otosyphilis with Hearing Loss
Next Article in Special Issue
Contributions of Net Charge on the PlyC Endolysin CHAP Domain
Previous Article in Journal
Antibiotic Discovery: Where Have We Come from, Where Do We Go?
Previous Article in Special Issue
Bystander Phage Therapy: Inducing Host-Associated Bacteria to Produce Antimicrobial Toxins against the Pathogen Using Phages
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessArticle

Directed Evolution of a Mycobacteriophage

1
Institute for Integrative Systems Biology (I2SysBio), Universitat de València-CSIC, 46980 Paterna, Valencia, Spain
2
Department of Genetics, Universitat de València, 46100 Burjassot, Valencia, Spain
*
Author to whom correspondence should be addressed.
Antibiotics 2019, 8(2), 46; https://doi.org/10.3390/antibiotics8020046
Received: 10 April 2019 / Revised: 22 April 2019 / Accepted: 23 April 2019 / Published: 25 April 2019
(This article belongs to the Special Issue Bacteriophages: Alternatives to Antibiotics and Beyond)
  |  
PDF [1707 KB, uploaded 13 May 2019]
  |  

Abstract

Bacteriophages represent an alternative strategy to combat pathogenic bacteria. Currently, Mycobacterium tuberculosis infections constitute a major public health problem due to extensive antibiotic resistance in some strains. Using a non-pathogenic species of the same genus as an experimental model, Mycobacterium smegmatis, here we have set up a basic methodology for mycobacteriophage growth and we have explored directed evolution as a tool for increasing phage infectivity and lytic activity. We demonstrate mycobacteriophage adaptation to its host under different conditions. Directed evolution could be used for the development of future phage therapy applications against mycobacteria. View Full-Text
Keywords: phage therapy; Mycobacterium smegmatis; mycobacteriophages; directed evolution phage therapy; Mycobacterium smegmatis; mycobacteriophages; directed evolution
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Cebriá-Mendoza, M.; Sanjuán, R.; Domingo-Calap, P. Directed Evolution of a Mycobacteriophage. Antibiotics 2019, 8, 46.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Antibiotics EISSN 2079-6382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top